State of Wyoming’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,564
Closed -$111K 1939
2025
Q1
$111K Buy
6,564
+3,455
+111% +$58.8K 0.01% 1127
2024
Q4
$57.4K Buy
+3,109
New +$60.7K 0.01% 1360
2023
Q4
Sell
-5,051
Closed -$135K 1672
2023
Q3
$135K Buy
5,051
+3,192
+172% +$109K 0.03% 696
2023
Q2
$68.8K Sell
1,859
-1,852
-50% -$64.6K 0.02% 1013
2023
Q1
$116K Sell
3,711
-1,653
-31% -$53.2K 0.04% 685
2022
Q4
$160K Buy
5,364
+2,544
+90% +$91K 0.05% 488
2022
Q3
$107K Buy
2,820
+1,777
+170% +$89.1K 0.05% 561
2022
Q2
$57K Buy
1,043
+1,030
+7,923% +$56.6K 0.04% 845
2022
Q1
$1K Sell
13
-208
-94% -$13.7K ﹤0.01% 1736
2021
Q4
$22K Buy
221
+198
+861% +$17.4K 0.01% 1439
2021
Q3
$2K Sell
23
-359
-94% -$32.6K ﹤0.01% 1154
2021
Q2
$35K Buy
382
+362
+1,810% +$28.9K 0.02% 829
2021
Q1
$2K Buy
+20
New +$2.06K ﹤0.01% 471

Other funds holding FLGT

State of Wyoming's FLGT Position: Q2 2025 in Review

State of Wyoming sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 6,564 shares — an estimated $111K sold.

State of Wyoming first reported a position in FLGT in Q1 2021 and held it in 13 quarters. The position peaked at $160K in Q4 2022. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • State of Wyoming reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • State of Wyoming sold 6,564 Fulgent Genetics shares in Q2 2025, an estimated $111K.
  • State of Wyoming first reported a position in Fulgent Genetics in Q1 2021 and held it in 13 quarters.
  • State of Wyoming's Fulgent Genetics position peaked at $160K in Q4 2022.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on State of Wyoming's 13F filing for Q2 2025, filed 19 Aug 2025.